North Star Investment Management Corp. bought a new position in Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 100,000 shares of the company’s stock, valued at approximately $921,000. North Star Investment Management Corp. owned about 0.26% of Viemed Healthcare as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of the business. State of Alaska Department of Revenue bought a new position in shares of Viemed Healthcare in the fourth quarter worth approximately $25,000. Kemnay Advisory Services Inc. bought a new stake in Viemed Healthcare during the fourth quarter valued at approximately $46,000. Quarry LP purchased a new position in Viemed Healthcare in the 3rd quarter worth approximately $48,000. AQR Capital Management LLC bought a new position in shares of Viemed Healthcare in the 1st quarter worth $90,000. Finally, SG Americas Securities LLC bought a new position in shares of Viemed Healthcare in the 4th quarter worth $101,000. Institutional investors own 74.24% of the company’s stock.
Viemed Healthcare Stock Performance
NASDAQ VMD opened at $11.39 on Tuesday. Viemed Healthcare, Inc. has a 52-week low of $5.93 and a 52-week high of $11.88. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.22. The company has a market capitalization of $436.66 million, a P/E ratio of 30.78 and a beta of 1.12. The company has a fifty day moving average of $9.95 and a 200-day moving average of $8.88.
Insider Transactions at Viemed Healthcare
In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total value of $230,000.00. Following the completion of the sale, the director owned 75,518 shares of the company’s stock, valued at $868,457. This represents a 20.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider William Frazier sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the transaction, the insider owned 73,214 shares in the company, valued at $858,068.08. The trade was a 12.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 20.00% of the company’s stock.
Viemed Healthcare Profile
Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.
Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.
Featured Articles
- Five stocks we like better than Viemed Healthcare
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
